X4 Pharmaceuticals, Inc. is a late clinical-stage company, which engages in the development and discovery of novel therapeutics for the treatment of rare diseases and those with limited treatment options. Its clinical candidate is mavorixafor. The company was founded by Henri A. Termeer, Keith T. Flaherty, Renato T. Skerlj, Richard Peters and Paula Ragan in 2010 and is headquartered in Boston, MA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
93
Frequently Asked Questions
What is Market Cap of X4 Pharmaceuticals Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. X4 Pharmaceuticals Inc market cap is $181.37M.
What is the 52-week high for X4 Pharmaceuticals Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. X4 Pharmaceuticals Inc 52 week high is $2.58 as of June 05, 2024.
What is the 52-week low for X4 Pharmaceuticals Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. X4 Pharmaceuticals Inc 52 week low is $0.5723 as of June 05, 2024.
What is X4 Pharmaceuticals Inc stock price today?
X4 Pharmaceuticals Inc stock price today is $1.08.
What was X4 Pharmaceuticals Inc stock price yesterday?
X4 Pharmaceuticals Inc stock price yesterday was $1.00.
What is the PE ratio of X4 Pharmaceuticals Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. X4 Pharmaceuticals Inc’s P/E ratio is -1.55.
What is the Price-to-Book ratio of X4 Pharmaceuticals Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. X4 Pharmaceuticals Inc P/B ratio is 175.0405.
What is X4 Pharmaceuticals Inc's EBITDA?
EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. X4 Pharmaceuticals Inc's EBITDA is -2.23.
What is the 50-day moving average of X4 Pharmaceuticals Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. X4 Pharmaceuticals Inc 50-day moving average is $1.16.
How many employess does X4 Pharmaceuticals Inc has?